Why Cannabis Helps Some People’s Anxiety and Makes Others Panic — The Science of Dose Response

It’s one of the most common paradoxes in cannabis: the same substance that millions of people use specifically to reduce anxiety is also one of the most common causes of anxiety-related emergency department visits. In 2025, “anxiety/panic” was the primary complaint in 38% of cannabis-related ED visits nationwide — nearly all in occasional or new users who consumed more than intended.

The explanation lies in a phenomenon called the biphasic dose-response curve, and a landmark 2026 study from the University of Chicago has provided the clearest evidence yet for how it works.

The Biphasic Effect

Most substances produce effects that increase linearly with dose — more alcohol means more intoxication, more caffeine means more alertness. Cannabis doesn’t follow this pattern. Instead, THC produces opposite effects at different doses, following a U-shaped curve.

Low doses (2.5-10mg THC): Reduced anxiety, enhanced relaxation, mild euphoria. At these doses, THC activates CB1 receptors in the amygdala (the brain’s fear center) at a level that enhances the release of the calming neurotransmitter GABA without overwhelming the system. Neuroimaging shows decreased amygdala reactivity to threatening stimuli — the neural signature of reduced anxiety.

Moderate doses (10-20mg THC): A transition zone where effects vary significantly by individual. Some users remain in the anxiolytic (anti-anxiety) range. Others begin to experience increased heart rate, heightened sensory awareness, and mild anxiety. Genetic variations in CB1 receptor density and endocannabinoid metabolism largely determine where an individual falls.

High doses (20mg+ THC): Increased anxiety, paranoia, and potential panic in a significant percentage of users. At high doses, THC overstimulates CB1 receptors, triggering excessive norepinephrine release and activating the sympathetic nervous system — the same fight-or-flight response that characterizes anxiety disorders. The brain’s threat detection system goes into overdrive.

The University of Chicago study demonstrated this curve with remarkable precision. Researchers administered precise THC doses to 150 participants across four sessions (placebo, 5mg, 15mg, and 25mg) while measuring cortisol levels, heart rate variability, and subjective anxiety ratings. The 5mg dose reduced anxiety scores by 22% compared to placebo. The 15mg dose showed no significant change. The 25mg dose increased anxiety scores by 37%.

Why It Varies Between People

The biphasic curve exists for everyone, but the threshold doses where effects flip from anxiolytic to anxiogenic vary enormously between individuals. Several factors determine your personal curve.

Genetics: Variations in the CNR1 gene (which encodes the CB1 receptor) affect receptor density and sensitivity. People with certain CNR1 variants have fewer CB1 receptors and reach the overstimulation threshold at lower doses. A genetic test can now identify these variants, though commercial testing services for cannabinoid sensitivity are still in early stages.

Tolerance: Regular cannabis users develop CB1 receptor tolerance, shifting their entire dose-response curve to the right. A dose that would cause anxiety in a naive user may be anxiolytic for a daily user. This is why experienced users can consume amounts that would send a novice to the emergency room.

Baseline anxiety: Paradoxically, people with higher baseline anxiety levels are more susceptible to THC-induced anxiety at moderate doses. Their amygdala is already operating at elevated activity levels, making it easier for THC to push past the calming threshold into overstimulation.

CBD content: CBD modulates THC’s effects by acting as a negative allosteric modulator of CB1 receptors — it changes the shape of the receptor in a way that reduces THC’s binding efficiency. Products with balanced THC:CBD ratios produce flatter dose-response curves with a wider anxiolytic window and a higher anxiety threshold.

The CBD Factor

CBD alone has a simpler relationship with anxiety. Multiple controlled studies show consistent anxiolytic effects at doses of 25-75mg, with a relatively flat dose-response curve — meaning higher doses don’t produce the rebound anxiety that THC causes. The 2026 meta-analysis in Neurotherapeutics confirmed that CBD reduces anxiety across social anxiety disorder, generalized anxiety disorder, and PTSD with effect sizes comparable to first-line pharmaceutical treatments.

The mechanism differs from THC. CBD doesn’t directly activate CB1 receptors. Instead, it modulates serotonin 5-HT1A receptors (the same target as buspirone, a common anti-anxiety medication), reduces cortisol production, and enhances anandamide signaling by inhibiting the enzyme (FAAH) that breaks down this endogenous cannabinoid.

For anxiety management, the research increasingly supports CBD-dominant or balanced ratio products over high-THC options — particularly for users prone to THC-induced anxiety.

Practical Guidelines for Anxiety-Prone Users

The research translates into clear practical advice for anyone using cannabis who is concerned about anxiety.

Microdose. 2.5-5mg THC is the sweet spot for anxiolytic effects with minimal anxiety risk. Tinctures and precisely dosed edibles make this level of control feasible.

Add CBD. A 1:1 or 2:1 CBD:THC ratio provides the entourage benefits of THC with CBD’s protective ceiling against anxiety escalation.

Avoid inhalation for anxiety management. Smoking and vaping deliver THC to the brain in seconds, creating rapid concentration spikes that are more likely to trigger the anxiety response. Oral products produce a slower, more gradual onset that keeps blood levels in the anxiolytic range longer.

Control your environment. Set and setting matter enormously. Consuming cannabis in a safe, comfortable environment with trusted people significantly reduces anxiety risk at any dose. Novel or socially stressful environments amplify THC’s anxiety-promoting effects at moderate doses.

Know your history. If you’ve experienced cannabis-induced panic before, your threshold is likely lower than average. Respect that individual variation rather than assuming you’ll react differently next time.

The biphasic dose-response curve isn’t a flaw in cannabis — it’s fundamental pharmacology that applies to many substances. The difference with cannabis is that the gap between the therapeutic dose and the adverse-effect dose is smaller than most consumers realize, making dose precision not just beneficial but essential.